129 related articles for article (PubMed ID: 35617667)
1. Ovarian Masses in Patients With Breast Cancer.
Kang KA; Lee J; Kim HS; Park SY
J Comput Assist Tomogr; 2022 Sep-Oct 01; 46(5):716-721. PubMed ID: 35617667
[TBL] [Abstract][Full Text] [Related]
2. Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance.
Kato MK; Shida D; Yoneoka Y; Yoshida H; Miyasaka N; Kanemitsu Y; Kato T
Int J Clin Oncol; 2020 Sep; 25(9):1663-1671. PubMed ID: 32494980
[TBL] [Abstract][Full Text] [Related]
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
4. CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors.
Kim SH; Kim WH; Park KJ; Lee JK; Kim JS
J Comput Assist Tomogr; 1996; 20(3):393-8. PubMed ID: 8626898
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between ovarian metastasis from colorectal carcinoma and primary ovarian carcinoma: Evaluation of tumour markers and "mille-feuille sign" on computed tomography/magnetic resonance imaging.
Kurokawa R; Nakai Y; Gonoi W; Mori H; Tsuruga T; Makise N; Ushiku T; Abe O
Eur J Radiol; 2020 Mar; 124():108823. PubMed ID: 31935596
[TBL] [Abstract][Full Text] [Related]
7. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation.
Hann LE; Lui DM; Shi W; Bach AM; Selland DL; Castiel M
Radiology; 2000 Jul; 216(1):242-7. PubMed ID: 10887255
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography of ovarian masses.
Fukuda T; Ikeuchi M; Hashimoto H; Shakudo M; Oonishi M; Saiwai S; Nakazima H; Miyamoto T; Takashima E; Inoue Y
J Comput Assist Tomogr; 1986; 10(6):990-6. PubMed ID: 3023462
[TBL] [Abstract][Full Text] [Related]
10. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation.
Koyama T; Mikami Y; Saga T; Tamai K; Togashi K
Abdom Imaging; 2007 Nov; 32(6):784-95. PubMed ID: 17318680
[TBL] [Abstract][Full Text] [Related]
11. [Role of Ca-125 in the differential diagnosis of adnexal mass in breast cancer patients].
Grabiec M; Nowicki P; Walentowicz M; Greźlikowska U; Mierzwa T; Chmielewska W
Ginekol Pol; 2005 May; 76(5):371-6. PubMed ID: 16145856
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic spectrum of ovarian masses in women with breast cancer; magnetic resonance imaging: histopathology correlation.
Abd El hafez A; Monir A
Ann Diagn Pathol; 2013 Oct; 17(5):441-7. PubMed ID: 23891503
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
Park SY; Oh YT; Jung DC
Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
[TBL] [Abstract][Full Text] [Related]
14. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
15. The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
Shin JE; Choi HJ; Kim MH; Cho KS
Korean J Radiol; 2011; 12(4):456-62. PubMed ID: 21852906
[TBL] [Abstract][Full Text] [Related]
16. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Nougaret S; Lakhman Y; Molinari N; Feier D; Scelzo C; Vargas HA; Sosa RE; Hricak H; Soslow RA; Grisham RN; Sala E
AJR Am J Roentgenol; 2018 Apr; 210(4):918-926. PubMed ID: 29489407
[TBL] [Abstract][Full Text] [Related]
17. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
18. CT and MRI findings of type I and type II epithelial ovarian cancer.
Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
[TBL] [Abstract][Full Text] [Related]
19. The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
Lee JW; Lee JH; Cho A; Yun M; Lee JD; Kim YT; Kang WJ
Clin Nucl Med; 2015 Feb; 40(2):97-102. PubMed ID: 25546187
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of MRI in the differential diagnosis between benign and malignant ovarian tumors.
Zhang T; Yi X; Lu J; Fu A
Eur J Gynaecol Oncol; 2017; 38(2):257-262. PubMed ID: 29953791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
